======= CERS2 ======= == Gene Information == * **Official Symbol**: CERS2 * **Official Name**: ceramide synthase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=29956|29956]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96G23|Q96G23]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CERS2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CERS2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606920|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Suppresses the growth of cancer cells. May be involved in sphingolipid synthesis. |TRAM LAG1 CLN8| |negative regulation of Schwann cell migration| |negative regulation of Schwann cell proliferation involved in axon regeneration| |regulation of Schwann cell proliferation involved in axon regeneration| |regulation of Schwann cell migration| |negative regulation of glial cell migration| |regulation of Schwann cell proliferation| |negative regulation of Schwann cell proliferation| |sphingosine N-acyltransferase activity| |negative regulation of axon regeneration| |negative regulation of glial cell proliferation| |regulation of glial cell migration| |negative regulation of neuron projection regeneration| |regulation of axon regeneration| |regulation of neuron projection regeneration| |regulation of glial cell proliferation| |negative regulation of gliogenesis| |ceramide biosynthetic process| |ceramide metabolic process| |negative regulation of response to wounding| |sphingolipid biosynthetic process| |regulation of gliogenesis| |membrane lipid biosynthetic process| |negative regulation of neuron projection development| |sphingolipid metabolic process| |regulation of response to wounding| |negative regulation of cell projection organization| |membrane lipid metabolic process| |negative regulation of neuron differentiation| |nuclear membrane| |negative regulation of cell migration| |negative regulation of cell motility| |negative regulation of neurogenesis| |negative regulation of cellular component movement| |negative regulation of nervous system development| |negative regulation of locomotion| |negative regulation of cell development| |negative regulation of response to external stimulus| |regulation of neuron projection development| |amide biosynthetic process| |lipid biosynthetic process| |regulation of neuron differentiation| |negative regulation of cell population proliferation| |regulation of plasma membrane bounded cell projection organization| |negative regulation of cellular component organization| |regulation of cell projection organization| |negative regulation of cell differentiation| |regulation of cellular response to stress| |cellular amide metabolic process| |regulation of neurogenesis| |regulation of cell migration| |regulation of cell motility| |regulation of nervous system development| |regulation of cell development| |endoplasmic reticulum membrane| |negative regulation of developmental process| |cellular lipid metabolic process| |regulation of locomotion| |regulation of cellular component movement| |endoplasmic reticulum| |regulation of response to external stimulus| |negative regulation of multicellular organismal process| |lipid metabolic process| |organonitrogen compound biosynthetic process| |DNA binding| |regulation of response to stress| |generation of neurons| |regulation of cell population proliferation| |negative regulation of response to stimulus| |neurogenesis| |cellular nitrogen compound biosynthetic process| |regulation of cell differentiation| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp483|FTY720 3μM R08 exp483]]|-2.4| |[[:results:exp298|Sucrose 20000μM R06 exp298]]|-2.26| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.02| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-1.99| |[[:results:exp508|NN-Dimethylsphingosine 2.5μM R08 exp508]]|-1.96| |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|-1.85| |[[:results:exp144|PFI-3 10μM R03 exp144]]|-1.85| |[[:results:exp26|Oligomycin-A 20μM R00 exp26]]|-1.71| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|1.78| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|2.05| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|2.71| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|3.17| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 4/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|2/20| |lung|0/75| |lymphocyte|1/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3136 * **Expression level (log2 read counts)**: 6.8 {{:chemogenomics:nalm6 dist.png?nolink |}}